FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics
The U.S. Food and Drug Administration today issued a final guidance for industry, Postapproval Pregnancy Safety Studies, with recommendations on different methodologies that can be used in the...
Sign up to read the full analysisDocument type: News/Update. Agency: FDA. Published: 2026-05-08.
Why this matters to food and beverage teams
This news update is worth screening if your team tracks fda activity that could affect ingredients, labeling, plant operations, imports, or compliance timing.
The practical question is whether this changes food safety, labeling, operational compliance, or supplier risk. If it does, pull the source document and decide whether the item needs action now, monitoring, or no response.
Track this document and its deadlines
Get the full analysis, comment period alerts, and compliance calendar -- free for F&B professionals.
Sign Up Free